AssetMark Inc’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.9M Sell
958,390
-22,481
-2% -$564K 0.03% 382
2026
Q2
$28.1M Buy
980,871
+143,836
+17% +$4.57M 0.05% 296
2026
Q1
$26.3M Buy
837,035
+188,190
+29% +$5.93M 0.05% 280
2025
Q4
$19.1M Buy
648,845
+180,332
+38% +$5.01M 0.04% 334
2025
Q3
$11.8M Buy
468,513
+103,011
+28% +$2.51M 0.03% 410
2025
Q2
$8.77M Buy
365,502
+282,809
+342% +$6.56M 0.02% 452
2025
Q1
$1.89M Buy
82,693
+59,749
+260% +$1.44M 0.01% 737
2024
Q4
$581K Buy
22,944
+21,488
+1,476% +$545K ﹤0.01% 935
2024
Q3
$36.3K Buy
+1,456
New +$43.1K ﹤0.01% 1367

Other funds holding RTO

AssetMark Inc's RTO Position: Q3 2026 in Review

AssetMark Inc reduced its Rentokil (RTO) stake by 2.3% in Q3 2026, selling an estimated $564K and leaving 958,390 shares worth $18.9M. The position accounts for 0.03% of the portfolio, ranked #382.

AssetMark Inc first reported a position in RTO in Q3 2024 and has held it in 9 quarters since. The position peaked at $28.1M in Q2 2026. 73 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • AssetMark Inc held 958,390 shares of Rentokil worth $18.9M as of Q3 2026.
  • AssetMark Inc sold 22,481 Rentokil shares in Q3 2026, an estimated $564K.
  • Rentokil made up 0.03% of AssetMark Inc's portfolio in Q3 2026, its #382 holding.
  • AssetMark Inc first reported a position in Rentokil in Q3 2024 and has held it in 9 quarters since.
  • AssetMark Inc's Rentokil position peaked at $28.1M in Q2 2026.
  • 73 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.